Altern Ther Health Med. 2022 Sep;28(6):57-59.
Diabetic peripheral neuropathy (DPN) is a common complication occurring in both type 1 and type 2 diabetics. DPN may result in foot ulceration or lower-limb amputation.
This case was undertaken to evaluate the efficacy of ReBuilder® therapy in the treatment of diabetic peripheral neuropathy.
The case report is based on 3 selected patients, 2 males and 1 female. Each patient continued being managed by his/her primary care physician. No changes to allopathic medicine or diet were advised by our team. In addition to the allopathic therapy, we added ReBuilder® therapy, low level light therapy, vibration therapy and supplementation. The treatment period ranged from 17 to 20 weeks.
The data presented here show promise for future, larger, controlled studies on the use of ReBuilder® devices for the treatment of diabetic peripheral neuropathy pain.
糖尿病周围神经病变（DPN）是 1 型和 2 型糖尿病患者常见的并发症。DPN 可导致足部溃疡或下肢截肢。
本病例旨在评估 ReBuilder®治疗在治疗糖尿病周围神经病变中的疗效。
该病例报告基于 3 名选定的患者，2 名男性和 1 名女性。每位患者继续由其初级保健医生进行管理。我们的团队不建议改变对抗疗法药物或饮食。除了对抗疗法，我们还增加了 ReBuilder®治疗、低水平光疗、振动治疗和补充剂。治疗期为 17 至 20 周。
这里呈现的数据为未来更大规模的、对照性的 ReBuilder®设备治疗糖尿病周围神经病变疼痛的研究提供了希望。
